MetaCap

Haoxi Health Technology Limited Class A (HAO)

NASDAQ: HAOConsumer DiscretionaryAdvertisingUSD

1.60-0.21 (-11.60%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

HAO stock chart

Technical analysis

Key statistics

All statistics
EPS (TTM)
-$386.40
52-week range
1.60 – 4,352.00
Day range
1.60 – 1.75
Volume / Avg
8.11K / 84.59K
Beta
—

52-week range

$1.60$4,352.00

HAO stock today

Haoxi Health Technology (HAO) closed at $1.60 on Nov 20, down 11.60% (-$0.21), versus the S&P 500's 3.70% decline. Trading was light, with 8.11K shares changing hands, about 10% of the average daily volume. At this level, HAO sits near the bottom of its 52-week range of $1.60 to $4,352.00: 100.0% below the high and 0.0% above the low.

Haoxi Health Technology has posted a net loss over the last twelve months (EPS of -$386.40), so its P/E ratio is not meaningful.

Summary generated from market data by MetaCap's automated system. Methodology

About Haoxi Health Technology

Company profile

Haoxi Health Technology Limited, through its subsidiaries, provides online marketing solutions in China. It offers online marketing solutions, including online short video marketing solutions to advertisers through its media partners; and customized marketing solutions by planning, producing, placing, and optimizing online ads to help advertisers acquire, convert, and retain consumers on various online media platforms. The company places its ads through mainstream online short video and social media platforms, such as Toutiao, Douyin, WeChat, and Sina Weibo.

Industry
Advertising
Headquarters
Chaoyang
Employees
28
IPO year
2024

Financial highlights

Full financials

In fiscal 2026, Haoxi Health Technology generated $54.8 million in revenue, up 67.1% from fiscal 2025. Haoxi Health Technology reported a net loss of $9.5 million, compared with net income of $3.9 million a year earlier. Gross margin was 1.1% (down from 2.8%) and operating margin -17.6%.

Haoxi Health Technology annual revenue, net income and EPS
Fiscal yearFY 2026FY 2025FY 2024FY 2023FY 2022
Revenue$54.83M$32.80M$48.52M$28.23M$16.16M
Growth+67.14%-32.39%+71.88%+74.72%—
Net income$-9.54M$3.88M$1.29M$969.75K$244.59K
EPS (diluted)$-386.40$3,385.53$2,701.53$0.87$0.01

Haoxi Health Technology peers

Consumer Discretionary sector
HAO peer companies
CompanyPrice% ChgMarket capCompare
TNMGTNL Mediagene2.12-7.42%$1.61Mvs HAO
FCDHForcendra Holding Limited Class A2.38+6.73%$2.18Mvs HAO
YDKGYueda Digital Holding Class A0.7307-8.84%$4.04Mvs HAO
INUVInuvo Inc.0.275+3.66%$4.91Mvs HAO
SURGSurgePays Inc.0.106-23.63%$6.50Mvs HAO
SWAGStran & Company Inc.1.11-4.31%$20.60Mvs HAO
HHSHarte Hanks Inc.3.60-5.26%$26.84Mvs HAO
THRYThryv Holdings Inc.0.7251+4.45%$32.23Mvs HAO

Indexes, lists and sector

Haoxi Health Technology stock FAQ

What is Haoxi Health Technology's stock price today?

HAO last traded at $1.60 as of Nov 20, 4:00 PM EST, down 11.60% on the day. Prices are delayed at least 15 minutes.

What is the HAO 52-week high?

The 52-week high for HAO is $4,352.00 and the 52-week low is $1.60. The stock is currently 100.0% below its high.

Compare HAO